A surgeon who enhances the skeletal framework that defines your proportions — not the soft tissue that masks them. Filler placed at periosteal depth for projection, definition, and natural facial balance. Neuromodulators managed on a structured maintenance timeline. Every treatment builds on the last.
I enhance structure, not soft tissue. Filler placed against bone creates projection, definition, and proportion. It produces a true improvement in facial architecture — not puffiness, heaviness, or trend-driven distortion.
Documented, surgeon-administered structural care. Every session is built on anatomy, tracked in your chart, and designed to advance your long-term facial architecture plan.
From structural assessment to long-term maintenance arc, every phase is anatomically guided, surgeon-administered, and designed for progressive improvement — not one-off correction.
Facial proportions, skeletal framework, tissue quality, and movement patterns evaluated by Dr. Ramirez Gavidia. Your anatomy dictates the plan — not a trend or a treatment menu.
Filler placed at periosteal depth to enhance bony projection, definition, and proportion. Neuromodulators calibrated to balance dynamic movement without freezing expression.
In-office structural review. Post-treatment photos compared to baseline. Any refinement performed. Your progressive improvement arc is updated in your chart.
Neuromodulator intervals set at 3–4 months. Structural filler reviewed annually. Each session advances the plan — not just replacing what was absorbed, but progressively refining architecture.
Two complementary systems. Structural filler rebuilds the skeletal framework that defines your proportions. Neuromodulators manage dynamic movement and prevent deepening static lines. The right plan uses both strategically.
Pricing discussed during consultation. Every structural plan is individualized based on your anatomy, proportional goals, and long-term timeline — not a units-only price list.
Your face is not a single-appointment problem. These pathways represent how structural enhancement progresses over time — each session building on the last to refine proportion, strengthen framework, and slow the aging trajectory.
This is not “come back when it wears off.” It is a progressive treatment arc — the RG Protocol — where each session builds on the last: refining structure, improving symmetry, and creating a compounding trajectory that makes you look better at year six than at year one. Your patient dashboard tracks every unit, every zone, every milestone.
Structural enhancement is not a single appointment — it is a multi-year evolution. Each phase builds on the last: restoring framework, refining proportion, and compounding improvement over time. The difference between year one and year six is not just maintenance — it is transformation.
The key insight: Without the protocol, time works against your facial structure. With it, every session compounds — rebuilding framework, refining proportions, and creating a trajectory where you look better at year six than you did at year one. This is not anti-aging. This is structural evolution.
Not generic “treatment areas” — each zone targets specific skeletal landmarks to create proportional, architectural improvement.
Click any zone to explore the structural enhancement.
Meet with Dr. Ramirez Gavidia for a surgeon-led structural assessment. Evaluate your facial architecture, discuss proportional goals, and begin your RG Protocol Arc — a progressive, multi-year plan built around anatomy, balance, and compounding structural improvement.
Injectable treatments at RG Aesthetic Plastic Surgery are performed by Dr. Roberto Ramirez Gavidia, a double board-certified plastic surgeon (ABPS + ABS), using FDA-approved dermal fillers and neuromodulators. All treatment decisions are made following appropriate medical evaluation based on individual anatomy. Structural filler is placed at depth to enhance bony framework and facial proportion. Individual results vary. Injectable products carry risks including bruising, swelling, asymmetry, and, rarely, vascular events — fully reviewed during the consent process. The “2–3 syringes per decade” guideline is a general framework and does not constitute a specific treatment recommendation without in-person evaluation.